{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:59:19Z","timestamp":1792508359697,"version":"4.5.0"},"reference-count":231,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.radonc.2022.05.027","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T01:53:09Z","timestamp":1653961989000},"page":"119-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children"],"prefix":"10.1016","volume":"173","author":[{"given":"Bianca A.W.","family":"Hoeben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Seravalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam E.","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Losert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Boterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Ospovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Mico Milla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candan","family":"Demiroz Abakay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Engellau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilberg","family":"J\u00f3hannesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Llagostera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bierings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scarzello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Seiersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrahams","family":"Ocanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren M.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria A.","family":"Kobyzeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Loginova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert O.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.05.027_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1398-2265.2004.00203.x","article-title":"History of pediatric stem cell transplantation","volume":"8","author":"Storb","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0010","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood-2011-01-331835","article-title":"Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0015","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0020","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/bmt.2016.139","article-title":"Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters","volume":"51","author":"Bresters","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11912-018-0719-5","article-title":"Long-term effects of myeloablative allogeneic hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia","volume":"20","author":"Lawitschka","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.radonc.2022.05.027_b0030","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood-2009-06-229369","article-title":"Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"116","author":"Sun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0268-960X(92)90019-M","article-title":"Conditioning regimens for allogeneic bone marrow transplantation","volume":"6","author":"Copelan","year":"1992","journal-title":"Blood Rev"},{"key":"10.1016\/j.radonc.2022.05.027_b0040","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1016\/j.bbmt.2011.12.348","article-title":"Trends in utilization of Total Body Irradiation (Tbi) prior to Hematopoietic Cell Transplantation (Hct) worldwide","volume":"18","author":"Hong","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0045","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.radonc.2022.05.027_b0050","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/bmt.2008.47","article-title":"Current European practice in pediatric myeloablative conditioning","volume":"41","author":"Vettenranta","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5144\/1658-3876.2011.17","article-title":"Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis","volume":"4","author":"Gupta","year":"2011","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.radonc.2022.05.027_b0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.774348","article-title":"Total body irradiation in haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia: review of the literature and future directions","volume":"9","author":"Hoeben","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.radonc.2022.05.027_b0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2020.10.032","article-title":"Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working group","volume":"155","author":"Hoeben","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0075","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijrobp.2021.07.1715","article-title":"Practice patterns of pediatric total body irradiation techniques: a children's oncology group survey","volume":"111","author":"Rassiah","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1748-717X-8-92","article-title":"Total Body Irradiation (TBI) using Helical Tomotherapy in children and young adults undergoing stem cell transplantation","volume":"8","author":"Gruen","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13014-019-1445-3","article-title":"Novel rotatable tabletop for total-body irradiation using a linac-based VMAT technique","volume":"14","author":"Losert","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/acm2.12257","article-title":"Volumetric modulated arc therapy for total body irradiation: a feasibility study using Pinnacle(3) treatment planning system and Elekta Agility linac","volume":"19","author":"Symons","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0095","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/S1470-2045(20)30342-9","article-title":"Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia","volume":"21","author":"Wong","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0100","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1200\/JCO.2014.58.9747","article-title":"Stem-cell transplantation in children with acute lymphoblastic leukemia: a prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial","volume":"33","author":"Peters","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0105","unstructured":"EudraCT Number: 2018-001795-38. ALLTogether1\u2013 A Treatment study protocol of the ALLTogether Consortium for children and young adults (0-45 years of age) with newly diagnosed acute lymphoblastic leukaemia (ALL). 2020."},{"key":"10.1016\/j.radonc.2022.05.027_b0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbmt.2016.11.022","volume":"23","author":"Lucchini","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0115","doi-asserted-by":"crossref","unstructured":"de Berranger E, Cousien A, Petit A, Peffault de Latour R, Galambrun C, Bertrand Y, et al. Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Bone Marrow Transplant. 2014;49:382-8.","DOI":"10.1038\/bmt.2013.185"},{"key":"10.1016\/j.radonc.2022.05.027_b0120","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.bmt.1704285","article-title":"Myeloablative conditioning regimens for AML allografts: 30 years later","volume":"32","author":"Gupta","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0125","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bbmt.2018.03.002","article-title":"Second hematopoietic stem cell transplantation for post-transplantation relapsed acute leukemia in children: a retrospective EBMT-PDWP study","volume":"24","author":"Yaniv","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/sj.leu.2404537","article-title":"Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia","volume":"21","author":"Yoshimi","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.radonc.2022.05.027_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092075","article-title":"Treatment and outcome analysis of 639 relapsed non-hodgkin lymphomas in children and adolescents and resulting treatment recommendations","volume":"13","author":"Burkhardt","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2022.05.027_b0140","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/bloodadvances.2018026203","article-title":"Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients","volume":"3","author":"Naik","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.radonc.2022.05.027_b0145","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.20.00157","article-title":"Stem cell transplantation and vinblastine monotherapy for relapsed pediatric anaplastic large cell lymphoma: results of the international, prospective ALCL-relapse","volume":"38","author":"Knorr","year":"2020","journal-title":"Trial J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0150","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fped.2019.00433","article-title":"Hematopoietic stem cell transplantation in inborn errors of metabolism","volume":"7","author":"Tan","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.radonc.2022.05.027_b0160","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2015.117","article-title":"Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes","volume":"50","author":"Peffault de Latour","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0165","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bmt.2014.306","article-title":"Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP","volume":"50","author":"Lawitschka","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0170","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3324\/haematol.2015.132860","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation","volume":"101","author":"Storb","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.radonc.2022.05.027_b0175","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1182\/bloodadvances.2019000449","article-title":"More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling","volume":"3","author":"Bader","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.radonc.2022.05.027_b0180","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.24252","article-title":"Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age","volume":"60","author":"Mulcahy Levy","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0185","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bbmt.2017.04.017","article-title":"Survival and late effects after allogeneic hematopoietic cell transplantation for hematologic malignancy at less than three years of age","volume":"23","author":"Vrooman","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0190","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/pbc.21207","article-title":"Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age","volume":"49","author":"Perkins","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1203\/01.pdr.0000199550.71887.ba","article-title":"Patterns of growth and body proportions after total-body irradiation and hematopoietic stem cell transplantation during childhood","volume":"59","author":"Bakker","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.radonc.2022.05.027_b0200","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/bmt.2008.217","article-title":"Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning","volume":"42","author":"Smedler","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0205","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1200\/JCO.2014.56.2223","article-title":"Cognitive outcome after pediatric stem-cell transplantation: impact of age and total-body irradiation","volume":"32","author":"Willard","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2018.05.067","article-title":"Radiation in central nervous system leukemia: guidelines from the International Lymphoma Radiation Oncology Group","volume":"102","author":"Pinnix","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejca.2021.03.034","article-title":"Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials","volume":"151","author":"Eckert","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.777108","article-title":"Minimal residual disease prior to and after haematopoietic stem cell transplantation in children and adolescents with acute lymphoblastic leukaemia: What level of negativity is relevant?","volume":"9","author":"Merli","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.radonc.2022.05.027_b0225","doi-asserted-by":"crossref","unstructured":"Carreras E., Rambaldi A. Evaluation and counseling of candidates. In: Carreras E., Dufour C., Mohty M., Kr\u00f6ger N., editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. Cham (CH): Springer Copyright 2019, EBMT and the Author(s). 2019. p. 77-86.","DOI":"10.1007\/978-3-030-02278-5_11"},{"key":"10.1016\/j.radonc.2022.05.027_b0230","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbmt.2016.12.623","article-title":"Cardiovascular risk factors in survivors of childhood hematopoietic cell transplantation treated with total body irradiation: a longitudinal analysis","volume":"23","author":"Friedman","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0240","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bmt.1703683","article-title":"Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal study","volume":"30","author":"Kupst","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0245","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41409-017-0055-7","article-title":"Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT","volume":"53","author":"Buchbinder","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0250","series-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","first-page":"421","article-title":"Endocrine disorders, fertility and sexual health","author":"Salooja","year":"2019"},{"key":"10.1016\/j.radonc.2022.05.027_b0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/bmt.2011.78","article-title":"Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence","volume":"47","author":"Borgmann-Staudt","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0260","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/EJE-13-0694","article-title":"Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence","volume":"170","author":"Vatanen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.radonc.2022.05.027_b0265","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.bmt.1705455","article-title":"Final height and gonad function after total body irradiation during childhood","volume":"38","author":"Couto-Silva","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0270","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaapos.2005.06.002","article-title":"Ocular complications after organ and bone marrow transplantation in children","volume":"9","author":"Bradfield","year":"2005","journal-title":"J AAPOS"},{"key":"10.1016\/j.radonc.2022.05.027_b0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijrobp.2014.07.049","article-title":"Dose response for radiation cataractogenesis: a meta-regression of hematopoietic stem cell transplantation regimens","volume":"91","author":"Hall","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0280","first-page":"353","article-title":"Oral complications of pediatric hematopoietic cell transplantation: diagnosis and management","volume":"8","author":"Majorana","year":"2000","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0285","doi-asserted-by":"crossref","first-page":"e28552","DOI":"10.1002\/pbc.28552","article-title":"The impact of pediatric hematopoietic stem cell transplant timing and psychosocial factors on family and caregiver adjustment","volume":"67","author":"Chardon","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0290","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbmt.2014.06.035","article-title":"Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors","volume":"21","author":"Hashmi","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0295","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/bmt.2012.76","article-title":"Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?","volume":"48","author":"Linhares","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0300","series-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","first-page":"331","article-title":"Chronic graft-versus-host disease","author":"Wolff","year":"2019"},{"key":"10.1016\/j.radonc.2022.05.027_b0305","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.radonc.2022.05.027_b0310","series-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","first-page":"393","article-title":"Noninfectious pulmonary complications","author":"Carreras","year":"2019"},{"key":"10.1016\/j.radonc.2022.05.027_b0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bmt.1704549","article-title":"Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre","volume":"34","author":"Bruno","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0320","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/thx.54.2.131","article-title":"Late pulmonary sequelae after childhood bone marrow transplantation","volume":"54","author":"Cerveri","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.radonc.2022.05.027_b0325","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bmt.1705710","article-title":"Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies","volume":"40","author":"Ferry","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0330","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/pbc.20531","article-title":"Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation","volume":"47","author":"Hoffmeister","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0335","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/pbc.24702","article-title":"Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years","volume":"60","author":"Kunkele","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0340","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"Rizzo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2016.203","article-title":"Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT","volume":"52","author":"DeFilipp","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0350","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2014.3","article-title":"Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study","volume":"49","author":"Bernard","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0355","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2002.03527.x","article-title":"Endocrine late effects after bone marrow transplant","volume":"118","author":"Brennan","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.radonc.2022.05.027_b0360","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ecl.2007.07.002","article-title":"Endocrine complications of hematopoietic stem cell transplantation","volume":"36","author":"Chemaitilly","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.radonc.2022.05.027_b0365","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.10773","article-title":"High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases","volume":"95","author":"Tauchmanova","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0370","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2007.02930.x","article-title":"Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood","volume":"67","author":"Bakker","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.radonc.2022.05.027_b0375","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bmt.2011.139","article-title":"Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or\/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)","volume":"47","author":"Isfan","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0380","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood-2004-07-2528","article-title":"Final adult height of patients who received hematopoietic cell transplantation in childhood","volume":"105","author":"Sanders","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0385","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045","article-title":"Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation","volume":"87","author":"Sanders","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0390","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1083-8791(00)70039-5","article-title":"Mechanisms of osteoporosis after hematopoietic cell transplantation","volume":"6","author":"Weilbaecher","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0395","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2001.v7.pm11400947","article-title":"Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study","volume":"7","author":"Stern","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bmt.2010.198","article-title":"Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients","volume":"46","author":"McClune","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0405","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bmt.1702763","article-title":"Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial","volume":"27","author":"Patzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0410","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/bjh.13148","article-title":"Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study","volume":"168","author":"Horwitz","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.radonc.2022.05.027_b0415","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2011.10.013","article-title":"Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation","volume":"49","author":"Soci\u00e9","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.radonc.2022.05.027_b0420","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bmt.2015.63","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation","volume":"50","author":"Inamoto","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0425","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/S1470-2045(20)30688-4","article-title":"Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"22","author":"Bowers","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0430","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.bmt.1703290","article-title":"Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood","volume":"28","author":"Cohen","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0435","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/blood-2007-07-099283","article-title":"Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party","volume":"111","author":"Friedman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0440","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0360-3016(80)90241-2","article-title":"Total body irradiation conference: discussion: the radiobiological bases of TBI","volume":"6","author":"Peters","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0445","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1148\/131.1.243","article-title":"Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation","volume":"131","author":"Peters","year":"1979","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2022.05.027_b0450","first-page":"4109","article-title":"Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT","volume":"93","author":"Cohen","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0455","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0360-3016(84)90163-9","article-title":"Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation","volume":"10","author":"Deeg","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0460","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0360-3016(82)90083-9","article-title":"Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation","volume":"8","author":"Thomas","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0465","first-page":"151","article-title":"Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation","volume":"1","author":"Deeg","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0470","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0145-2126(82)90104-7","article-title":"Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse","volume":"6","author":"Clift","year":"1982","journal-title":"Leuk Res"},{"key":"10.1016\/j.radonc.2022.05.027_b0475","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0480","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0485","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/1097-0142(19920601)69:11<2853::AID-CNCR2820691135>3.0.CO;2-2","article-title":"Total-body irradiation before bone marrow transplantation. Results of two randomized instantaneous dose rates in 157 patients","volume":"69","author":"Ozsahin","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0490","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0360-3016(98)00077-7","article-title":"Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation","volume":"41","author":"Belkacemi","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0495","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0167-8140(87)80197-4","article-title":"Total body irradiation\u2013review of treatment techniques in Europe","volume":"9","author":"Quast","year":"1987","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0500","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2141.1989.tb00254.x","article-title":"The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation","volume":"73","author":"Frassoni","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.radonc.2022.05.027_b0505","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0360-3016(89)90105-3","article-title":"Total body irradiation in acute myeloid leukemia and chronic myelogenous leukemia: influence of dose and dose-rate on leukemia relapse","volume":"17","author":"Scarpati","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0510","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0360-3016(92)90909-2","article-title":"Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide\u2013a phase I trial","volume":"23","author":"Petersen","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0515","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0520","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2005.02.032","article-title":"Dose response and factors related to interstitial pneumonitis after bone marrow transplant","volume":"63","author":"Sampath","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0525","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1200\/JCO.2000.18.2.348","article-title":"New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia","volume":"18","author":"Socie","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0530","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.2018874115","article-title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","volume":"133","author":"Baker","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2022.05.027_b0535","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0936-6555(05)80695-8","article-title":"Fractionated total body irradiation: some radiobiological considerations","volume":"5","author":"Muller-Runkel","year":"1993","journal-title":"Clin Oncol (Royal College of Radiologists (Great Britain))"},{"key":"10.1016\/j.radonc.2022.05.027_b0540","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-8140(86)80035-4","article-title":"Fractionated versus low dose-rate total body irradiation. Radiobiological considerations in the selection of regimes","volume":"7","author":"O\u2019Donoghue","year":"1986","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0545","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1259\/0007-1285-60-711-279","article-title":"The implications of in-vitro radiation-survival curves for the optimal scheduling of total-body irradiation with bone marrow rescue in the treatment of leukaemia","volume":"60","author":"O'Donoghue","year":"1987","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2022.05.027_b0550","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijrobp.2018.06.015","article-title":"Single-dose daily fractionation is not inferior to twice-a-day fractionated total-body irradiation before allogeneic stem cell transplantation for acute leukemia: a useful practice simplification resulting from the SARASIN study","volume":"102","author":"Belkacemi","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0555","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41409-019-0470-z","article-title":"Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation","volume":"54","author":"Sengelov","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0560","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbmt.2005.12.029","article-title":"A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission","volume":"12","author":"Marks","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0565","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbmt.2017.04.002","article-title":"Dose escalation of total marrow irradiation in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Hui","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0570","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0167-8140(85)80122-5","article-title":"Effect of dose-rate on total body irradiation: lethality and pathologic findings","volume":"4","author":"Travis","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-8140(90)90161-O","article-title":"Radiobiological aspects of continuous low dose-rate irradiation and fractionated high dose-rate irradiation","volume":"19","author":"Turesson","year":"1990","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0580","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0360-3016(87)90046-0","article-title":"Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man","volume":"13","author":"Tarbell","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0585","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00066-006-1528-6","article-title":"Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation","volume":"182","author":"Kal","year":"2006","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2022.05.027_b0590","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijrobp.2019.02.034","article-title":"Higher reported lung dose received during total body irradiation for allogeneic hematopoietic stem cell transplantation in children with acute lymphoblastic leukemia is associated with inferior survival: a report from the Children's Oncology Group","volume":"104","author":"Esiashvili","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0595","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1200\/JCO.2000.18.5.981","article-title":"Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies","volume":"18","author":"Girinsky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0600","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11604-007-0157-z","article-title":"Total body irradiation followed by bone marrow transplantation: comparison of once-daily and twice-daily fractionation regimens","volume":"25","author":"Soejima","year":"2007","journal-title":"Radiat Med"},{"key":"10.1016\/j.radonc.2022.05.027_b0605","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.785916","article-title":"Optimized conformal total body irradiation among recipients of TCRalphabeta\/CD19-depleted grafts in pediatric patients with hematologic malignancies: single-center experience","volume":"11","author":"Kobyzeva","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0610","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-8140(99)00178-4","article-title":"Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation","volume":"54","author":"Buchali","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0615","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1532\/IJH97.05046","article-title":"Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis","volume":"83","author":"Oya","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1016\/j.radonc.2022.05.027_b0620","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0360-3016(94)00446-R","article-title":"Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Societe Francaise de Greffe de Moelle","volume":"31","author":"Resbeut","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0625","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jpepsy\/jsm080","article-title":"Factors related to changes in cognitive, educational and visual motor integration in children who undergo hematopoietic stem cell transplant","volume":"33","author":"Barrera","year":"2008","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.radonc.2022.05.027_b0630","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0360-3016(95)02178-7","article-title":"Toxicities of total-body irradiation for pediatric bone marrow transplantation","volume":"34","author":"Chou","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0635","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2466\/pms.1989.68.3c.1227","article-title":"Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy","volume":"68","author":"Parth","year":"1989","journal-title":"Percept Mot Skills"},{"key":"10.1016\/j.radonc.2022.05.027_b0640","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1651-2227.1990.tb11525.x","article-title":"Sensory-motor and cognitive functioning in children who have undergone bone marrow transplantation","volume":"79","author":"Smedler","year":"1990","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.radonc.2022.05.027_b0645","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/bmt.2008.370","article-title":"Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI","volume":"43","author":"Bernard","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0650","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.semnephrol.2010.09.010","article-title":"Chronic kidney disease after hematopoietic stem cell transplantation","volume":"30","author":"Cohen","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.radonc.2022.05.027_b0655","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/BF01957523","article-title":"Growth following single fraction and fractionated total body irradiation for bone marrow transplantation","volume":"152","author":"Thomas","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.radonc.2022.05.027_b0660","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijrobp.2015.10.054","article-title":"Factors influencing pulmonary toxicity in children undergoing allogeneic hematopoietic stem cell transplantation in the setting of total body irradiation-based myeloablative conditioning","volume":"94","author":"Abugideiri","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0665","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0360-3016(97)00578-6","article-title":"High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications","volume":"40","author":"Bradley","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0670","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0360-3016(95)00115-F","article-title":"Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I\/II trial","volume":"32","author":"Demirer","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0675","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.21873\/anticanres.11049","article-title":"Treatment complications and long-term outcomes of total body irradiation in patients with acute lymphoblastic leukemia: a single institute experience","volume":"36","author":"Df","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2022.05.027_b0680","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1200\/JCO.2000.18.18.3273","article-title":"Late effects of treatment in survivors of childhood acute myeloid leukemia","volume":"18","author":"Leung","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0685","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00066-010-2089-2","article-title":"Total body irradiation (TBI) in pediatric patients. A single-center experience after 30 years of low-dose rate irradiation","volume":"186","author":"Linsenmeier","year":"2010","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2022.05.027_b0690","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(96)00246-5","article-title":"A comparison of single-dose and fractionated total-body irradiation on the development of pneumonitis following bone marrow transplantation","volume":"36","author":"Morgan","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0695","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijrobp.2007.05.035","article-title":"Long-term outcome after static intensity-modulated total body radiotherapy using compensators stratified by pediatric and adult cohorts","volume":"70","author":"Schneider","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0700","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/sj.bjc.6601751","article-title":"Total body irradiation and pneumonitis risk: a review of outcomes","volume":"90","author":"Carruthers","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0705","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0936-6555(98)80034-4","article-title":"Toxicity and dosimetry of fractionated total body irradiation prior to allogeneic bone marrow transplantation using a straightforward radiotherapy technique","volume":"10","author":"Gerrard","year":"1998","journal-title":"Clin Oncol (Royal College of Radiologists (Great Britain))"},{"key":"10.1016\/j.radonc.2022.05.027_b0710","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0360-3016(89)90446-X","article-title":"Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant","volume":"17","author":"Lawton","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0715","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0360-3016(95)02063-2","article-title":"Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation","volume":"34","author":"Ozsahin","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0720","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bbmt.2009.05.016","article-title":"Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Abboud","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0725","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ijrobp.2007.12.009","article-title":"Impact of drug therapy, radiation dose, and dose rate on renal toxicity following bone marrow transplantation","volume":"71","author":"Cheng","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0730","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbmt.2005.08.036","article-title":"The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation","volume":"12","author":"Delgado","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0735","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","article-title":"Chronic kidney disease after hematopoietic cell transplantation: a systematic review","volume":"8","author":"Ellis","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0740","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2008.09.017","article-title":"Renal toxicity in children undergoing total body irradiation for bone marrow transplant","volume":"90","author":"Esiashvili","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0745","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bmt.1703312","article-title":"Renal function after autologous bone marrow transplantation in children: a long-term prospective study","volume":"29","author":"Frisk","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0750","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00066-009-2022-8","article-title":"Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT)","volume":"185","author":"Gerstein","year":"2009","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2022.05.027_b0755","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bmt.1705662","article-title":"Long-term renal function following bone marrow transplantation","volume":"39","author":"Gronroos","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0760","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1705573","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplant","volume":"39","author":"Hingorani","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0765","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1705110","article-title":"Long-term renal function after hemopoietic stem cell transplantation in children","volume":"36","author":"Kist-van Holthe","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0167-8140(90)90195-3","article-title":"Renal insufficiency after total body irradiation for pediatric bone marrow transplantation","volume":"18","author":"Tarbell","year":"1990","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0775","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00066-005-1405-8","article-title":"Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks","volume":"181","author":"Igaki","year":"2005","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2022.05.027_b0780","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.1996.14.2.579","article-title":"Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease","volume":"14","author":"Miralbell","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0785","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.bmt.1701022","article-title":"Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation","volume":"20","author":"Lawton","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0790","first-page":"3305","article-title":"Induction of severe cataract and late renal dysfunction following total body irradiation: dose-effect relationships","volume":"29","author":"Kal","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2022.05.027_b0795","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF03038482","article-title":"Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients","volume":"174","author":"Belkacemi","year":"1998","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.radonc.2022.05.027_b0800","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0360-3016(94)90056-6","article-title":"Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates","volume":"28","author":"Ozsahin","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0805","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1600-0420.2007.00991.x","article-title":"Visual outcome and cataract development after allogeneic stem-cell transplantation in children","volume":"85","author":"Fahnehjelm","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.radonc.2022.05.027_b0810","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ijrobp.2005.04.031","article-title":"Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant","volume":"63","author":"Faraci","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0815","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/bloodadvances.2019001126","article-title":"Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia","volume":"4","author":"Lee","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.radonc.2022.05.027_b0820","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00066-009-1008-x","article-title":"Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies","volume":"185","author":"Ricardi","year":"2009","journal-title":"Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]"},{"key":"10.1016\/j.radonc.2022.05.027_b0825","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bmt.1704076","article-title":"Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits","volume":"31","author":"van Kempen-Harteveld","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0830","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctro.2021.08.009","article-title":"Influence of eye movement on lens dose and optic nerve target coverage during craniospinal irradiation","volume":"31","author":"Hoeben","year":"2021","journal-title":"Clin Transl Radiat Oncolo"},{"key":"10.1016\/j.radonc.2022.05.027_b0835","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bbmt.2015.10.016","article-title":"Implications and management of central nervous system involvement before allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia","volume":"22","author":"Aldoss","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0840","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/1097-0142(19891101)64:9<1796::AID-CNCR2820640907>3.0.CO;2-7","article-title":"Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission","volume":"64","author":"Ganem","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.05.027_b0845","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2008.07.002","article-title":"Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Oshima","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0850","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.2015.64.2850","article-title":"Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy","volume":"34","author":"Vora","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0855","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbmt.2017.11.013","article-title":"Augmenting total body irradiation with a cranial boost before stem cell transplantation protects against post-transplant central nervous system relapse in acute lymphoblastic leukemia","volume":"24","author":"Gao","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0860","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.prro.2016.06.008","article-title":"Low-dose cranial boost in high-risk adult acute lymphoblastic leukemia patients undergoing bone marrow transplant","volume":"7","author":"Su","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0865","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0360-3016(96)00272-6","article-title":"Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group","volume":"36","author":"Cherlow","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0870","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2017.01.067","article-title":"Phase I trial of total marrow and lymphoid irradiation transplantation conditioning in patients with relapsed\/refractory acute leukemia","volume":"23","author":"Stein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0875","unstructured":"Stein A, Tsai N-C, Palmer J, Al Malki M, Aldoss I, Ali H, et al. Total marrow and lymphoid irradiation (TMLI) in combination with cyclophosphamide and Etoposide in patients with relapsed\/refractory acute leukemia undergoing allogeneic hematopoietic cell transplantation. Presented at 2019 European Society for Blood and Marrow Transplantation Meeting, Frankfurt, Germany, March 24-27, 2019. 2019."},{"key":"10.1016\/j.radonc.2022.05.027_b0880","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/bmt.2015.228","article-title":"Childhood to adult transition and long-term follow-up after blood and marrow transplantation","volume":"51","author":"Cupit","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0885","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbmt.2016.09.011","article-title":"National institutes of health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report","volume":"23","author":"Bevans","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b0890","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/COC.0b013e31826e0528","article-title":"American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI)","volume":"36","author":"Wolden","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0895","doi-asserted-by":"crossref","unstructured":"Van Dyk J., Galvin J.M,. Glasgow G.P., Podgorsak E.B. AAPM REPORT NO. 17: The physical aspects of total and half body photon irradiation. 1986.","DOI":"10.37206\/16"},{"key":"10.1016\/j.radonc.2022.05.027_b0900","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0971-6203.25664","article-title":"Whole body radiotherapy: A TBI-guideline","volume":"31","author":"Quast","year":"2006","journal-title":"J Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0905","first-page":"71","article-title":"CT-based analysis of dose homogeneity in total body irradiation using lateral beam","volume":"5","author":"Hui","year":"2004","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0910","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1120\/jacmp.v16i2.5293","article-title":"TBI lung dose comparisons using bilateral and anteroposterior delivery techniques and tissue density corrections","volume":"16","author":"Bailey","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0915","series-title":"Report 34 of the Netherlands Commission on Radiation Dosimetry","article-title":"Code of practice and recommendations for total body irradiation and total skin irradiation","author":"Murrer","year":"2021"},{"key":"10.1016\/j.radonc.2022.05.027_b0920","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2018.04.071","article-title":"Total Body irradiation: guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"101","author":"Wong","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0925","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1120\/jacmp.v17i3.6128","article-title":"Effect of electron contamination on in vivo dosimetry for lung block shielding during TBI","volume":"17","author":"Narayanasamy","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0930","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ijrobp.2007.07.2334","article-title":"Total body irradiation, toward optimal individual delivery: dose evaluation with metal oxide field effect transistors, thermoluminescence detectors, and a treatment planning system","volume":"69","author":"Bloemen-van Gurp","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0935","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0360-3016(97)00286-1","article-title":"The influence of x-ray energy on lung dose uniformity in total-body irradiation","volume":"38","author":"Ekstrand","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0940","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0958-3947(98)00029-6","article-title":"Partial lung shield for TBI","volume":"23","author":"Ho","year":"1998","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2022.05.027_b0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tipsro.2019.05.002","article-title":"A step and shoot intensity modulated technique for total body irradiation","volume":"10","author":"Fog","year":"2019","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0950","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2006.02.021","article-title":"Renal dysfunction after total body irradiation: dose-effect relationship","volume":"65","author":"Kal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0955","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0971-6203.103607","article-title":"Patient dose analysis in total body irradiation through in vivo dosimetry","volume":"37","author":"Ganapathy","year":"2012","journal-title":"J Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b0960","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF02742397","article-title":"The accuracy of dose determination during total body irradiation","volume":"175","author":"Malicki","year":"1999","journal-title":"Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]"},{"key":"10.1016\/j.radonc.2022.05.027_b0965","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13014-015-0362-3","article-title":"Intensity-modulated Total Body Irradiation (TBI) with TomoDirect","volume":"10","author":"Salz","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0970","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canrad.2017.06.014","article-title":"Total body irradiation using Helical Tomotherapy((R)): treatment technique, dosimetric results and initial clinical experience","volume":"22","author":"Sarradin","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2022.05.027_b0975","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.zemedi.2019.05.002","article-title":"Total body irradiation: significant dose sparing of lung tissue achievable by helical tomotherapy","volume":"30","author":"Wilhelm-Buchstab","year":"2020","journal-title":"Z Med Phys"},{"issue":"113","key":"10.1016\/j.radonc.2022.05.027_b0980","first-page":"e1","article-title":"Volumetric modulated arc therapy enabled total body irradiation (VMAT-TBI): six-year clinical experience and treatment outcomes","volume":"28","author":"Zhang-Velten","year":"2022","journal-title":"Transplant Cellular Therapy"},{"key":"10.1016\/j.radonc.2022.05.027_b0985","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phro.2017.11.002","article-title":"Volumetric modulated arc therapy based total body irradiation: workflow and clinical experience with an indexed rotational immobilization system","volume":"4","author":"Ouyang","year":"2017","journal-title":"Phys Imag Radiat Onc"},{"key":"10.1016\/j.radonc.2022.05.027_b0990","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.radonc.2018.08.005","article-title":"Total-body irradiation using linac-based volumetric modulated arc therapy: its clinical accuracy, feasibility and reliability","volume":"129","author":"Tas","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b0995","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13014-016-0625-7","article-title":"Total body irradiation with volumetric modulated arc therapy: dosimetric data and first clinical experience","volume":"11","author":"Springer","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1000","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/jrr\/rraa078","article-title":"Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study","volume":"61","author":"Konishi","year":"2020","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2022.05.027_b1005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/bmt.2010.237","article-title":"Clinical feasibility of TBI with helical tomotherapy","volume":"46","author":"Pe\u00f1agar\u00edcano","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b1010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.radonc.2019.07.010","article-title":"Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: a global health initiative by the international consortium of total marrow irradiation","volume":"141","author":"Zuro","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3857\/roj.2020.00528","article-title":"Total marrow and lymphoid irradiation with helical tomotherapy: a practical implementation report","volume":"38","author":"Chilukuri","year":"2020","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2022.05.027_b1020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.13675","article-title":"Organ sparing total marrow irradiation compared to total body irradiation prior to allogeneic stem cell transplantation","volume":"107","author":"Haraldsson","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.radonc.2022.05.027_b1025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ejmp.2015.05.012","article-title":"Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT","volume":"31","author":"Mancosu","year":"2015","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2022.05.027_b1030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.radonc.2011.06.005","article-title":"Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation","volume":"102","author":"Han","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2018.04.016","article-title":"SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy","volume":"128","author":"Ajithkumar","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.meddos.2016.06.001","article-title":"Dosimetric evaluation of total marrow irradiation using 2 different planning systems","volume":"41","author":"Nalichowski","year":"2016","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2022.05.027_b1045","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1120\/jacmp.v13i1.3653","article-title":"Anatomy driven optimization strategy for total marrow irradiation with a volumetric modulated arc therapy technique","volume":"13","author":"Mancosu","year":"2012","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b1050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2011.01.023","article-title":"Cranio-spinal irradiation with volumetric modulated arc therapy: a multi-institutional treatment experience","volume":"99","author":"Fogliata","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1055","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.rpor.2016.03.002","article-title":"Reducing the dosimetric impact of positional errors in field junctions for craniospinal irradiation using VMAT","volume":"21","author":"Strojnik","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.radonc.2022.05.027_b1060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.prro.2021.02.010","article-title":"A step toward making VMAT TBI more prevalent: automating the treatment planning process","volume":"11","author":"Simiele","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canrad.2017.07.047","article-title":"A low gradient junction technique of craniospinal irradiation using volumetric-modulated arc therapy and its advantages over the conventional therapy","volume":"22","author":"Sarkar","year":"2018","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2022.05.027_b1070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1120\/jacmp.v16i6.5580","article-title":"Virtual bolus for total body irradiation treated with helical tomotherapy","volume":"16","author":"Moliner","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b1075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/acm2.13287","article-title":"Effect of auto flash margin on superficial dose in breast conserving radiotherapy for breast cancer","volume":"22","author":"Wang","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b1080","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1088\/0031-9155\/49\/21\/005","article-title":"The effect of optimization on surface dose in intensity modulated radiotherapy (IMRT)","volume":"49","author":"Thomas","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2022.05.027_b1085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.meddos.2009.07.001","article-title":"Dosimetric study and verification of total body irradiation using helical tomotherapy and its comparison to extended SSD technique","volume":"35","author":"Zhuang","year":"2010","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2022.05.027_b1090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13014-019-1296-y","article-title":"Effect of changes in monitor unit rate and energy on dose rate of total marrow irradiation based on Linac volumetric arc therapy","volume":"14","author":"Son","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.meddos.2018.12.003","article-title":"Appropriate treatment planning method for field joint dose in total body irradiation using helical tomotherapy","volume":"44","author":"Usui","year":"2019","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2022.05.027_b1100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-015-0391-y","article-title":"In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study","volume":"10","author":"Mancosu","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmp.2019.03.032","article-title":"Implementing safe and robust total marrow irradiation using helical tomotherapy - a practical guide","volume":"60","author":"Haraldsson","year":"2019","journal-title":"Phys Medica"},{"key":"10.1016\/j.radonc.2022.05.027_b1110","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1118\/1.2044428","article-title":"Feasibility study of helical tomotherapy for total body or total marrow irradiation","volume":"32","author":"Hui","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b1115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.radonc.2022.05.027_b1120","series-title":"Total marrow irradiation","first-page":"1","article-title":"Total marrow irradiation: redefining the role of radiotherapy in bone marrow transplantation","author":"Wong","year":"2020"},{"key":"10.1016\/j.radonc.2022.05.027_b1125","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s12094-019-02205-9","article-title":"TLI in pediatric patients","volume":"22","author":"Ocanto","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2022.05.027_b1130","series-title":"Total Marrow irradiation","first-page":"187","article-title":"Acute and late toxicities with total marrow irradiation","author":"Shinde","year":"2020"},{"key":"10.1016\/j.radonc.2022.05.027_b1135","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijrobp.2019.08.010","article-title":"Radiation-related toxicities using organ sparing total marrow irradiation transplant conditioning regimens","volume":"105","author":"Shinde","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b1140","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijrobp.2010.11.035","article-title":"Total marrow irradiation with RapidArc volumetric arc therapy","volume":"81","author":"Aydogan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b1145","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ijrobp.2010.11.028","article-title":"Preclinical assessment of volumetric modulated arc therapy for total marrow irradiation","volume":"80","author":"Fogliata","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b1150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2014.01.036","article-title":"Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"89","author":"Kim","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.05.027_b1155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.meddos.2020.11.003","article-title":"Simple template-based optimization for pediatric total lymphoid irradiation (TLI) radiotherapy treatments","volume":"46","author":"Ferrer","year":"2021","journal-title":"Med Dosim"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022041330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022041330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:22:44Z","timestamp":1759123364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022041330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":231,"alternative-id":["S0167814022041330"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.05.027","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}